Financials TerrAscend Corp.

Equities

TSND

CA88105E1088

Drug Retailers

Market Closed - Toronto S.E. 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
2.28 CAD +4.59% Intraday chart for TerrAscend Corp. -0.44% +3.64%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 310 1,549 1,173 296.2 476.7 485.2 - -
Enterprise Value (EV) 1 365.5 1,705 1,279 475.4 476.7 652.1 685.2 485.2
P/E ratio -1.41 x -12 x 615 x -0.85 x -4.74 x -37.9 x 45.4 x 8.33 x
Yield - - - - - - - -
Capitalization / Revenue 5.12 x 9.8 x 5.57 x 1.2 x 1.5 x 1.4 x 1.26 x 1.1 x
EV / Revenue 6.03 x 10.8 x 6.08 x 1.92 x 1.5 x 1.88 x 1.78 x 1.1 x
EV / EBITDA -19.3 x 35.6 x 19.5 x 12.2 x 6.93 x 8.63 x 7.63 x 4.33 x
EV / FCF - -80.6 x -17.7 x -7.23 x - 20.1 x 27.4 x 80.9 x
FCF Yield - -1.24% -5.65% -13.8% - 4.98% 3.66% 1.24%
Price to Book 4.05 x 169 x 4.98 x 0.98 x - 3.08 x - -
Nbr of stocks (in thousands) 141,879 155,321 190,880 259,125 287,271 291,298 - -
Reference price 2 2.185 9.971 6.145 1.143 1.659 1.666 1.666 1.666
Announcement Date 4/23/20 3/23/21 3/16/22 3/16/23 3/14/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 60.59 158 210.4 247.8 317.3 347.2 385.6 440.2
EBITDA 1 -18.96 47.85 65.64 38.84 68.8 75.57 89.77 112
EBIT 1 -45.92 47.56 23.48 -23.74 41.44 41.09 46.98 75.8
Operating Margin -75.78% 30.11% 11.16% -9.58% 13.06% 11.84% 12.18% 17.22%
Earnings before Tax (EBT) 1 - -100.8 34.45 -310.2 -58.83 19.77 44.95 73.8
Net income 1 -154.1 -123.6 3.111 -329.9 -95.54 -13.59 16.28 54.2
Net margin -254.26% -78.22% 1.48% -133.12% -30.11% -3.91% 4.22% 12.31%
EPS 2 -1.549 -0.8285 0.0100 -1.350 -0.3500 -0.0440 0.0367 0.2000
Free Cash Flow 1 - -21.16 -72.28 -65.75 - 32.48 25.05 6
FCF margin - -13.39% -34.35% -26.53% - 9.36% 6.5% 1.36%
FCF Conversion (EBITDA) - - - - - 42.98% 27.9% 5.35%
FCF Conversion (Net income) - - - - - - 153.88% 11.07%
Dividend per Share - - - - - - - -
Announcement Date 4/23/20 3/23/21 3/16/22 3/16/23 3/14/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 49.14 49.2 49.66 64.8 67.02 66.34 69.4 72.12 89.24 85.55 81.4 85.26 88.49 90.79
EBITDA 1 10.5 11.86 3.287 5.768 11.32 18.46 12.21 12.82 24.15 19.63 15.3 18.17 20.01 20.6
EBIT 1 3.826 0.3 -10.03 -14 -8.054 8.346 5.724 2.498 16.96 16.26 8.174 10.19 11.71 11.82
Operating Margin 7.79% 0.61% -20.2% -21.61% -12.02% 12.58% 8.25% 3.46% 19% 19.01% 10.04% 11.95% 13.23% 13.02%
Earnings before Tax (EBT) 1 66.44 -15.71 -12.26 18.85 -345 28.25 -10.1 -6.407 5.104 -51.02 1.239 3.536 5.098 6.227
Net income 1 60.37 -17.31 -16.36 13.22 -313.2 -13.56 -22.77 -15.62 -10.6 -44.14 -8.895 -7.661 -6.63 -5.738
Net margin 122.86% -35.17% -32.94% 20.4% -467.31% -20.43% -32.81% -21.66% -11.88% -51.59% -10.93% -8.99% -7.49% -6.32%
EPS 2 0.3300 -0.1000 -0.0800 0.0500 -1.230 -0.0300 -0.0900 -0.0500 -0.0400 -0.1600 -0.0275 -0.0250 -0.0225 -0.0175
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 11/16/21 3/16/22 5/12/22 8/11/22 11/14/22 3/16/23 5/11/23 8/10/23 11/9/23 3/14/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 55.5 156 106 179 - 167 200 -
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) -2.927 x 3.259 x 1.607 x 4.615 x - 2.21 x 2.228 x -
Free Cash Flow 1 - -21.2 -72.3 -65.8 - 32.5 25.1 6
ROE (net income / shareholders' equity) - - - -14.1% - -5.7% 11.4% -
ROA (Net income/ Total Assets) - - 0.3% -5.98% - -2.35% 8.2% -
Assets 1 - - 1,024 5,521 - 578.2 198.5 -
Book Value Per Share 2 0.5400 0.0600 1.230 1.170 - 0.5400 - -
Cash Flow per Share 2 -0.3400 0.1800 -0.1800 -0.1100 - -0.0700 - -
Capex 1 - 47.5 40.5 39.6 - 14.7 6.7 -
Capex / Sales - 30.04% 19.23% 15.99% - 4.25% 1.74% -
Announcement Date 4/23/20 3/23/21 3/16/22 3/16/23 3/14/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
1.666 USD
Average target price
3.1 USD
Spread / Average Target
+86.15%
Consensus
  1. Stock Market
  2. Equities
  3. TSND Stock
  4. Financials TerrAscend Corp.